Private Equity
We partner with many leading conglomerates and innovative companies in Korea to address their business needs in future growth and in capital resources. Our strategy is to seek untapped opportunities where we can add value while others overlook.
Venture Capital
We make investments in early-stage companies, seeking to unlock values from core-technology and management philosophy, and help the companies grow by supporting in revenue generating activities.
Our Portfolio
EnsolBio Sciences
2021 Korea
Innovative new drugs to cure the incurables investment of bio blind fund
Airovation Technologies
2021 Korea
Innovative Air-Tech company that provides original, patented air purification and carbon capture solutions investment
Bertis
2022 Korea
Breast cancer early diagnosis biotech(series investment) NASDAQ and KOSDAQ listing candidate
Kinosmedicine
2021 Korea
Innovative medicines for brain diseases, cancers, and infectious disease investment of bio blind fund
